{
    "clinical_study": {
        "@rank": "144469", 
        "arm_group": [
            {
                "arm_group_label": "Desloratadine + Prednisolone", 
                "arm_group_type": "Experimental", 
                "description": "The patients will take 2 tablets three times a day, as follows:\nMorning: 1 tablet of the test medication(Desloratadine 5 mg + Prednisolone 20 mg) + 1 tablet of placebo control medication.\nAfternoon: 1 tablet of placebo test medication + 1 tablet of placebo control medication.\nNight: 1 tablet of placebo test medication + 1 tablet of placebo control medication."
            }, 
            {
                "arm_group_label": "Dexchlorpheniramine + Betamethasone", 
                "arm_group_type": "Active Comparator", 
                "description": "The patients will take 2 tablets three times a day, as follows:\nMorning: 1 tablet of the control medication(Dexchlorpheniramine 2mg + Betamethasone 0.25mg) + 1 tablet of placebo test medication.\nAfternoon: 1 tablet of the control medication(Dexchlorpheniramine 2mg + Betamethasone 0.25mg) + 1 tablet of placebo test medication.\nNight: 1 tablet of the control medication(Dexchlorpheniramine 2mg + Betamethasone 0.25mg) + 1 tablet of placebo test medication."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the non-inferiority clinical efficacy of two\n      different drug associations in the treatment of Moderate - Severe Persistent Allergic\n      Rhinitis in Adults."
        }, 
        "brief_title": "Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": "Rhinitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed Consent of the patient;\n\n          -  Clinical diagnosis of moderate - severe persistent allergic rhinitis according to\n             ARIA classification(Allergic Rhinitis and Its Impact on Asthma);\n\n          -  Adults aged \u2265 18 years old;\n\n          -  Evidence of sensitization to aeroallergens in examination (immediate skin tests or\n             serum specific IgE) in the 12 months prior to inclusion.\n\n        Exclusion Criteria:\n\n          -  Decongestants dependent patients or patients receiving allergen specific\n             immunotherapy;\n\n          -  Patients who were in use of oral antihistamines or decongestants in the past 15 days;\n\n          -  Patients who were treated with systemic corticosteroids in the last month;\n\n          -  Patients on treatment with monoamine oxidase inhibitors (MAOIs);\n\n          -  Patients with history of hypersensitivity to  any of the formula compounds;\n\n          -  Patients with any clinically significant disease that in the investigator opinion can\n             not participate in the study\n\n          -  Patients who have uncontrolled asthma, chronic sinusitis, drug related rhinitis and\n             nasal anatomic abnormalities.\n\n          -  Participation in clinical trial in 30 days prior to study entry;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "234", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720485", 
            "org_study_id": "DPCEMS0812"
        }, 
        "intervention": [
            {
                "arm_group_label": "Desloratadine + Prednisolone", 
                "description": "1 tablet 3 times a day", 
                "intervention_name": "Desloratadine + Prednisolone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Dexchlorpheniramine + Betamethasone", 
                "description": "1 tablet 3 times a day", 
                "intervention_name": "Dexchlorpheniramine + Betamethasone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Betamethasone-17,21-dipropionate", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Betamethasone", 
                "Prednisolone", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Betamethasone sodium phosphate", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate", 
                "Dexchlorpheniramine", 
                "Chlorpheniramine", 
                "Desloratadine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 24, 2013", 
        "location": {
            "contact": {
                "email": "daniela.fakih@imabrasil.com", 
                "last_name": "Fabio M Castro, MD", 
                "phone": "55 11 38639156"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil"
                }, 
                "name": "IMA - Instituto de Pesquisa Cl\u00ednica e Medicina Avan\u00e7ada"
            }, 
            "investigator": {
                "last_name": "Fabio M Castro, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double-blind,Double Dummy, Randomized, Multicenter Parallel-group Study on Efficacy of Desloratadine and Prednisolone Association Compared to Dexchlorpheniramine and Betamethasone Association in Adults With Moderate - Severe Persistent Allergic Rhinitis", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Health Surveillance Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The mean variability of nasal symptoms score observed between visit 1 and visit 2 will be used as the primary endpoint of clinical efficacy.", 
            "measure": "Efficacy of treatment in persistent allergic rhinitis based on nasal symptoms score", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720485"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Adverse events will be collected and followed in order to evaluate safety and tolerability", 
            "measure": "Safety will be evaluated by the adverse events occurrences", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "source": "EMS", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EMS", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}